NCT02055963 2022-10-20Minocycline for Postsurgical Symptom Reduction in Head and Neck CancerM.D. Anderson Cancer CenterPhase 2 Terminated30 enrolled 9 charts
NCT01173692 2021-08-20Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study.M.D. Anderson Cancer CenterPhase 2 Completed47 enrolled 7 charts
NCT01427205 2013-04-05Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)M.D. Anderson Cancer CenterPhase 2 Withdrawn